A Special Interview with Tekmira Pharmaceuticals by PropThink

published on 2013-10-04T14:35:18Z

A Special Interview with Tekmira Pharmaceuticals PropThink, a leading healthcare-focused provider of investment research and analysis, hosted an interview and investor Q&A conference call with Dr. Mark Murray, Chief Executive Officer and President of Tekmira Pharmaceuticals (TKMR) (TSX:TKM), on Thursday, October 3, 2013.

Genre: TKMR

Your current browser isn't compatible with SoundCloud.
Please download one of our supported browsers. Need help?

Chrome | Firefox | Safari | Edge

Sorry! Something went wrong

Is your network connection unstable or browser outdated?

I need help